Cryptogenic vs. NASH-cirrhosis: The rose exists well before its name….

Journal of Hepatology

Volumn 68, Issue 3, 2018, Pages 391-392

  Caldwell, Stephen ^a   Marchesini, Giulio ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE HEPATITIS; BILIARY TRACT DISEASE; DIABETES MELLITUS; EDITORIAL; HEPATITIS VIRUS; HUMAN; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; FIBROSIS; ROSE;

FIBROSIS; HUMANS; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ROSA;

EID: 85039547378     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2017.12.006     Document Type: Editorial

References (12)

1. Powell, E.E., Cooksley, W.G., Hanson, R., Searll, J., Halliday, J.W., Powell, L.W., The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11 (1990), 74–80.
2. Caldwell, S.H., Oelsner, D.H., Iezzoni, J.C., Hespenheide, E.E., Battle, E.H., Driscoll, C.J., Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29 (1999), 664–669.
3. Poonawala, A., Nair, S.P., Thuluvath, P.J., Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32 (2000), 689–692.
4. Clark, J.M., Diehl, A.M., Nonalcoholic fatty liver disease: An under-recognized cause of cryptogenic cirrhosis. JAMA 289 (2003), 3000–3004.
5. Caldwell, S.H., Crespo, D.M., The spectrum expanded: cryptogenic cirrhosis and the natural history of nonalcoholic fatty liver disease. J Hepatol 40 (2004), 578–584.
6. Caldwell, S.H., Lee, V.D., Kleiner, D.E., Al-Osaimi, A.M., Argo, C.K., Northup, P.G., et al. NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol 8 (2009), 346–352.
7. Thuluvath PJ, Kantsevoy S, Thuluvath AJ, Savva Y. Is cryptogenic cirrhosis different from NASH cirrhosis? J Hepatol 2018;68:519–525.
8. Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (2003), 917–923.
9. Crawford, D.H.G., Shepherd, R.W., Halliday, J.W., Cooksley, G.W.G.E., Golding, S.D., Cheng, W.S.C., et al. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments. Gastroenterology 106 (1994), 1611–1617.
10. Berg, T., Neuhaus, R., Klein, R., Leder, K., Lobeck, H., Bechstein, W.O., et al. Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): a long-term documentation before and after OLT. Transplantation 74 (2002), 792–798.
11. Ayata, G., Gordon, F.D., Lewis, W.D., Pomfret, E., Pomposelli, J.J., Jenkins, R.L., et al. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol 33 (2002), 1098–1104.
12. Hayashi, P.H., Harrison, S.A., Torgerson, S., Perez, T.A., Nochajski, T., Russell, M., Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. Am J Gastroenterol 99 (2004), 76–81.